Patents by Inventor Paige N. Davis

Paige N. Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BUPIVACAINE MULTIVESICULAR LIPOSOME FORMULATIONS AND USES THEREOF
    Publication number: 20230133849
    Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising high concentration of bupivacaine for the purpose of preventing, treating or ameliorating pain, for example, post-surgical pain for an extended period of time. Processes of making and administering bupivacaine encapsulated multivesicular liposome formulations (BUP-MVLs) and their uses as medicaments are also provided.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 4, 2023
    Inventors: Louie D. Garcia, Soroush M. Ardekani, Paige N. Davis, Stephanie M. Kurz, Damon A. Leon, Kathleen D.A. Los, John J. Grigsby, JR., Eran Levy, Alisha R. Simonian
  • MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXAMETHASONE
    Publication number: 20230137783
    Abstract: Some embodiments of the present application are related to multivesicular liposome (MVL) formulations encapsulating dexamethasone or an ester or an ester salt thereof, for example, dexamethasone sodium phosphate (DSP) that may provide about 3-28 days extended release of dexamethasone. Processes of making and administering dexamethasone encapsulated multivesicular liposome formulations and their uses for treating pain or inflammation are also provided.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 4, 2023
    Inventors: Paige N. Davis, Soroush M. Ardekani, Stephanie M. Kurz, Louie D. Garcia, Kathleen D.A. Los, John J. Grigsby, JR., Damon A. Leon, Eran Levy, Alisha R. Simonian
  • MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINE
    Publication number: 20220273568
    Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising dexmedetomidine (DXM) for the purpose of minimizing the side effects of immediate release formulation of dexmedetomidine while lengthening the duration of the effect with clinically meaniningful efficacy. Processes of making and administering DXM encapsulated multivesicular liposome formulations (DXM-MVLs) and their uses as medicaments are also provided.
    Type: Application
    Filed: July 9, 2020
    Publication date: September 1, 2022
    Inventors: Soroush M. Ardekani, Patrick GHL. Boen, Louie D. Garcia, Paige N. Davis, Hassan G. Hussein, Kathleen D. A. Los
  • COMPOSITIONS OF BUPIVACAINE MULTIVESICULAR LIPOSOMES
    Publication number: 20220233442
    Abstract: Embodiments of the present application relate to compositions of multivesicular liposomes (MVLs) and commercial manufacturing processes for making bupivacaine MVLs.
    Type: Application
    Filed: February 1, 2022
    Publication date: July 28, 2022
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, JR., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMES
    Publication number: 20220233446
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Application
    Filed: January 22, 2021
    Publication date: July 28, 2022
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, JR., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D.A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11357727
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: June 14, 2022
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11311486
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: April 26, 2022
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11304904
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: April 19, 2022
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11278494
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: March 22, 2022
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11185506
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: November 30, 2021
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11179336
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: November 23, 2021
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los
  • Manufacturing of bupivacaine multivesicular liposomes
    Patent number: 11033495
    Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: June 15, 2021
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Paige N. Davis, Louie D. Garcia, Stephanie M. Kurz, Kathleen D. A. Los